PMC:7321036 / 51037-51268 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T256","span":{"begin":90,"end":98},"obj":"Disease"},{"id":"T257","span":{"begin":101,"end":110},"obj":"Disease"}],"attributes":[{"id":"A256","pred":"mondo_id","subj":"T256","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A257","pred":"mondo_id","subj":"T257","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":"Kinases represent ideal drug targets; here, we identified kinases and pathways altered by SARS-CoV-2 infection that can be targeted by 87 FDA-approved drugs and compounds in clinical trials or in preclinical development (Table S8)."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T19979","span":{"begin":24,"end":28},"obj":"Chemical"},{"id":"T28590","span":{"begin":151,"end":156},"obj":"Chemical"},{"id":"T71374","span":{"begin":227,"end":229},"obj":"Chemical"}],"attributes":[{"id":"A95523","pred":"chebi_id","subj":"T19979","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"},{"id":"A87444","pred":"chebi_id","subj":"T28590","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"},{"id":"A96031","pred":"chebi_id","subj":"T71374","obj":"http://purl.obolibrary.org/obo/CHEBI_29385"}],"text":"Kinases represent ideal drug targets; here, we identified kinases and pathways altered by SARS-CoV-2 infection that can be targeted by 87 FDA-approved drugs and compounds in clinical trials or in preclinical development (Table S8)."}

{"project":"LitCovid-PubTator","denotations":[{"id":"1127","span":{"begin":90,"end":110},"obj":"Disease"}],"attributes":[{"id":"A1127","pred":"tao:has_database_id","subj":"1127","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Kinases represent ideal drug targets; here, we identified kinases and pathways altered by SARS-CoV-2 infection that can be targeted by 87 FDA-approved drugs and compounds in clinical trials or in preclinical development (Table S8)."}

{"project":"LitCovid-sentences","denotations":[{"id":"T337","span":{"begin":0,"end":231},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Kinases represent ideal drug targets; here, we identified kinases and pathways altered by SARS-CoV-2 infection that can be targeted by 87 FDA-approved drugs and compounds in clinical trials or in preclinical development (Table S8)."}